TGFBR1 and colorectal carcinoma: We also screened six other TGFBR1 variants with potential pathogenic effects and found no evidence of CRC risk association, in agreement with recent studies in Spanish and northern European populations (Castillejo et al, 2009; Carvajal-Carmona et al, 2010).